NCT06354387 2026-03-19
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
China Medical University Hospital
Phase 1 Completed
Clinical Trials
6 trialsNCT04551521 2025-01-08
CRAFT: The NCT-PMO-1602 Phase II Trial
German Cancer Research Center
Phase 2 Completed
NCT06339554 2024-04-01
TOSS-ALK
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT05081674 2023-10-11
BLISS
Hospital Israelita Albert Einstein
Phase 2 Completed
NCT03158389 2023-09-28
N²M²
University Hospital Heidelberg
Phase 1/2 Completed
NCT03779191 2023-07-06
Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
Instituto Nacional de Cancerologia de Mexico
Phase 2 Completed